D
에스엘에스바이오
246250KOSDAQ그외 기타 전문, 과학 및 기술 서비스업34.0 / 100
Reference Date: 2026-04-13
Financial Score4.5 / 40
News Sentiment12.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, PBR raises overvaluation concerns. Roughly flat over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
SLS Bio, established in 2007, specializes in pharmaceutical quality control, new drug development support, and in vitro diagnostic equipment. The company contributes to the pharmaceutical industry's advancement and public healthcare benefits through drug quality testing, generic drug promotion, and new drug development assistance.
Number of Employees
63people
Average Salary
35.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 59.134.0Point
PBR
3.96Industry Average 1.940.0Point
2.0x industry avg (risky)
ROE
-48.68Industry Average 1.530.0Point
Well below industry avg
Debt Ratio
26.32Industry Average 16.090.5Point
1.6x industry avg (risky)
Trend 2023~20250.0 / 10 points
Revenue Growth Rate
0.0 / 3
Avg ▼29.8% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼799.7% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -10.6% (declining, 3yr)
Detailed News Sentiment
2 totalPositive 0Neutral 0Negative 0
- Neutral
- Neutral
Detailed Momentum
52-week position3.0Point
52w lower range (35%)
Current 1,969Won52-week high 2,68552-week low 1,571
1-month return3.0Point
1m 0% (flat)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
3 totalPositive 0Neutral 3Negative 0
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
- Neutral정기주주총회결과2026-03-27
- Neutral사업보고서 (2025.12)2026-03-19